JVSNX | VMVAX | JVSNX / VMVAX | |
Total Expense Ratio | 0.69 | 0.07 | 986% |
Annual Report Gross Expense Ratio | 0.88 | 0.07 | 1,257% |
Fund Existence | 8 years | 14 years | - |
Gain YTD | 0.382 | 4.930 | 8% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 3000 | 33,333% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 85.1M | 32.5B | 0% |
Annual Yield % from dividends | 0.62 | 2.17 | 28% |
Returns for 1 year | -9.35 | 1.43 | -655% |
Returns for 3 years | 37.60 | 39.17 | 96% |
Returns for 5 years | 52.15 | 61.58 | 85% |
Returns for 10 years | N/A | 96.86 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
SCHV | 28.77 | 0.31 | +1.09% |
Schwab US Large-Cap Value ETF™ | |||
DEUS | 57.14 | 0.48 | +0.84% |
Xtrackers Russell US Multifactor ETF | |||
IMAR | 28.86 | 0.13 | +0.45% |
Innovator Intl Dev Pwr Bffr ETF - Mar | |||
GENW | 12.25 | N/A | N/A |
Genter Capital International Div ETF | |||
FAX | 15.59 | -0.06 | -0.38% |
abrdn Asia-Pacific Income Fund |